| Aurelia Metals Limited (AMI) ORDINARY FULLY PAID |
Materials |
$542 |
Dec 2024 Half Year Financial Results Presentation
|
26 Feb 2025 8:14AM |
$0.215 |
$0.320 |
risen by
48.84%
|
|
AMI - Price-sensitive ASX Announcement
Full Release
Key Points
- Underlying NPAT increased to $15.6 million from a loss of $1.8 million.
- Underlying EBITDA rose by 53% to $49.7 million.
- Cash balance at $96.7 million with no drawn debt.
- Gold production decreased to 21.5k oz from 31.7k oz.
- Improved copper and zinc production with positive operational performance.
- Focus on productivity improvements and ramping up Federation operations.
- Significant opportunity for growth through planned exploration and optimization projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ReadyTech Holdings Limited (RDY) ORDINARY FULLY PAID |
Information Technology |
$260 |
Half Year Results - Investor Presentation
|
26 Feb 2025 8:14AM |
$3.300 |
$2.130 |
fallen by
35.45%
|
|
RDY - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue increased by 6.6% to $58.3 million.
- Underlying EBITDA rose by 4.6% to $18.2 million.
- Subscription revenue grew by 5.7% to $49.9 million.
- Total cash EBITDA margin improved to 14.7%.
- Received largest contract win exceeding $1 million in Workforce Solutions.
- Acquisition of CouncilWise enhances local government service capabilities.
- AI solutions such as Talent IQ and Ask AI Policy Bot were launched.
- Confidence in a $37.5 million opportunity pipeline.
- Expectations for margin expansion in 2H FY25.
- Strong cash flow and balance sheet support further growth initiatives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aurelia Metals Limited (AMI) ORDINARY FULLY PAID |
Materials |
$542 |
Dec 2024 Half Year Financial Results
|
26 Feb 2025 8:14AM |
$0.215 |
$0.320 |
risen by
48.84%
|
|
AMI - Price-sensitive ASX Announcement
Full Release
Key Points
- Underlying EBITDA increased 53% to $49.7M.
- Statutory net profit after tax improved 984% to $18.0M.
- Cash flows from operating activities increased 55% to $53.1M.
- Strong cash balance of $96.7M with operations funding all growth capital.
- Group All-In-Sustaining-Cost margin increased 70% to $1,557/oz.
- Federation mine development increased to 1,491 metres.
- First production from Federation with 16.5kt ore processed at the Peak plant.
- Cobar Optimisation study completed recommending expansion of Peak plant.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kelsian Group Limited (KLS) ORDINARY FULLY PAID |
Industrials |
$839 |
1HFY25 Half Year Results & Capital Management Framework
|
26 Feb 2025 8:14AM |
$3.620 |
$3.090 |
fallen by
14.64%
|
|
KLS - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue up 9.1% to $1,071.8 million
- Underlying EBITDA up 1.3% to $132.2 million
- Underlying NPATA down 7.9% to $39.7 million
- Statutory Net Profit After Tax was $20.1 million
- Fully franked interim dividend of 8.0 cents per share
- Successful launch of Bankstown Rail Replacement service
- Renewed Bunbury & Busselton bus services contract worth $100 million
- Announced capital management framework targets
- Sale of three bus depots in Western Australia expected to realize ~$20.3 million
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Latitude Group Holdings Limited (LFS) ORDINARY FULLY PAID |
Financials |
$1,190 |
Update - Notification of buy-back - LFSPA
|
26 Feb 2025 8:14AM |
$1.200 |
$1.145 |
fallen by
4.58%
|
|
| Southern Cross Gold Consolidated Ltd (SX2) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$788 |
SX2 High-Grade Gold-Antimony Extends 200m West at Christina
|
26 Feb 2025 8:14AM |
$3.610 |
$5.700 |
risen by
57.89%
|
|
SX2 - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade gold-antimony mineralization extended by 200 meters west at Christina.
- Mineralized strike length now totals 1.5 km between Apollo East and Christina.
- New vein sets discovered, indicating further potential for mineralization.
- Drillhole SDDSC148 achieved multiple high-grade intersections.
- Upcoming catalysts include exploration target upgrades and ongoing expansion drilling.
- Project's significance increased due to China's export restrictions on antimony.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Credit Clear Limited (CCR) ORDINARY FULLY PAID |
Information Technology |
$93 |
1HY FY25 Investor Presentation
|
26 Feb 2025 8:13AM |
$0.285 |
$0.220 |
fallen by
22.81%
|
|
| Credit Clear Limited (CCR) ORDINARY FULLY PAID |
Information Technology |
$93 |
1H FY25 Results Summary
|
26 Feb 2025 8:13AM |
$0.285 |
$0.220 |
fallen by
22.81%
|
|
| Credit Clear Limited (CCR) ORDINARY FULLY PAID |
Information Technology |
$93 |
Half Yearly Report and Accounts
|
26 Feb 2025 8:13AM |
$0.285 |
$0.220 |
fallen by
22.81%
|
|
CCR - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 16% to $23.249 million.
- Net loss after tax was $2.174 million.
- Previous year's loss was $2.102 million.
- Strong onboarding of new clients contributed to revenue growth.
- The company focuses on digital collection technologies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aurelia Metals Limited (AMI) ORDINARY FULLY PAID |
Materials |
$542 |
Appendix 4D & Dec 2024 Half Year Financial Results
|
26 Feb 2025 8:13AM |
$0.215 |
$0.320 |
risen by
48.84%
|
|
AMI - Price-sensitive ASX Announcement
Full Release
Key Points
- Aurelia Metals Limited achieved a statutory net profit of $18.0 million for H1 FY25.
- The Federation Mine reached first production, contributing positively to the financial results.
- Dargues Mine ceased operations in August 2024, impacting overall production and costs.
- Peak Mine showed increased production with a gross profit of $32.1 million.
- Strong EBITDA growth was reported, reflecting improved operational performance.
- Focus on enhancing infrastructure and processing capabilities in the Cobar Basin.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Apiam Animal Health Limited (AHX) ORDINARY FULLY PAID |
Health Care |
$75 |
Half Yearly Report and Accounts
|
26 Feb 2025 8:13AM |
$0.415 |
$0.410 |
fallen by
1.20%
|
|
AHX - Price-sensitive ASX Announcement
Full Release
Key Points
- Group revenue increased to $106.2 million, up 1.7% from the previous year.
- Net profit after tax attributable to members was a loss of $1.5 million.
- The Clinical Vet Services segment's revenue declined due to paused dairy heifer exports to China.
- Apiam plans to divest underperforming clinics and has entered acquisition discussions for new clinics.
- An impairment charge of $4.5 million was recognized related to business divestments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Botanix Pharmaceuticals Ltd (BOT) ORDINARY FULLY PAID |
Health Care |
$909 |
Appendix 4D and Half Year Report
|
26 Feb 2025 8:13AM |
$0.505 |
$0.465 |
fallen by
7.92%
|
|
BOT - Price-sensitive ASX Announcement
Full Release
Key Points
- Botanix Pharmaceuticals is a clinical dermatology company marketing Sofdra, a treatment for primary axillary hyperhidrosis.
- The company reported a net loss of $30,888,119 for the half-year ended 31 December 2024.
- Sofdra was approved by the FDA on June 18, 2024, and initial prescriptions began in December 2024.
- Botanix incurred significant expenses in sales and marketing, totaling $8,862,001.
- The company expects Q1 2025 to be the first quarter of commercial revenue from Sofdra.
- Botanix has engaged 27 territory managers for the Sofdra launch and has completed sales training.
- The company has finalized terms with US commercial payers, making Sofdra accessible to 167 million lives.
- A successful Patient Experience Program provided insights for the broader product launch.
- The report indicates a material uncertainty regarding the company's ability to continue as a going concern.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ReadyTech Holdings Limited (RDY) ORDINARY FULLY PAID |
Information Technology |
$260 |
Half Year Results - Media Release
|
26 Feb 2025 8:12AM |
$3.300 |
$2.130 |
fallen by
35.45%
|
|
RDY - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue increased 6.6% to $58.3 million for 1H FY25
- Recurring revenue represented 85.6% of total revenue
- Net revenue retention was 102%
- Underlying EBITDA grew by 4.6% to $18.2 million
- Strong contributions from Education and Workforce Solutions
- Enterprise pipeline exceeds $37.5 million
- Strategic contract wins include entry into the University market
- Investment in R&D and Sales & Marketing at 29% and 8.6% of revenue respectively
- Expectations for double-digit growth in key segments
- Focus on innovation and AI-enhanced solutions
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MAAS Group Holdings Limited (MGH) ORDINARY FULLY PAID |
Industrials |
$1,596 |
Update - Notification of buy-back - MGH
|
26 Feb 2025 8:12AM |
$3.560 |
$4.400 |
risen by
23.60%
|
|
| Kelsian Group Limited (KLS) ORDINARY FULLY PAID |
Industrials |
$839 |
Dividend/Distribution - KLS
|
26 Feb 2025 8:12AM |
$3.620 |
$3.090 |
fallen by
14.64%
|
|
| Integral Diagnostics Limited (IDX) ORDINARY FULLY PAID |
Health Care |
$953 |
FY25 Half Year Results App4D and Interim Report
|
26 Feb 2025 8:12AM |
$2.860 |
$2.560 |
fallen by
10.49%
|
|
IDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 9.3% to $252.9 million.
- EBITDA rose 210.0% to $35.1 million.
- Net loss for the half-year was $396,000 compared to a loss of $66.8 million last year.
- A fully franked interim dividend of 2.5 cents per share was declared.
- The company completed the acquisition of Capitol Health Limited.
- Operating NPAT growth of 31.9% was reported before various costs.
- Strong free cash flow growth of 22.7% was achieved.
- Net debt to EBITDA ratio improved to 2.8x.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ReadyTech Holdings Limited (RDY) ORDINARY FULLY PAID |
Information Technology |
$260 |
Appendix 4D and Interim Report
|
26 Feb 2025 8:12AM |
$3.300 |
$2.130 |
fallen by
35.45%
|
|
RDY - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 6.6% to $58.3 million.
- Reported a loss after tax of $18.7 million.
- Strong contributions from Education, Workforce Solutions, and Justice segments.
- Net revenue retention at 102%.
- Recurring revenue represented 85.6% of total revenue.
- Acquisition of CouncilWise expected to enhance local government offerings.
- Underlying EBITDA margin remains stable at 31.2%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tyro Payments Limited (TYR) ORDINARY FULLY PAID |
Financials |
$486 |
Tyro Payments H1 FY25 ASX Release
|
26 Feb 2025 8:12AM |
$0.895 |
$0.920 |
risen by
2.79%
|
|
TYR - Price-sensitive ASX Announcement
Full Release
Key Points
- Gross profit grew 6.5% on H1 FY24 to $112.0 million.
- EBITDA grew 20.6% on H1 FY24 to $33.0 million.
- Net profit before tax doubled to $10.3 million.
- Strong free cash flow of $9.0 million.
- 34% growth in banking users.
- Tyro Health delivered 16.2% increase in transaction volume.
- Tyro reaffirms FY25 guidance of gross profit between $218 million and $226 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tyro Payments Limited (TYR) ORDINARY FULLY PAID |
Financials |
$486 |
Tyro Payments H1 FY25 Investor Presentation
|
26 Feb 2025 8:12AM |
$0.895 |
$0.920 |
risen by
2.79%
|
|
TYR - Price-sensitive ASX Announcement
Full Release
Key Points
- H1 FY25 results show strong growth with gross profit of $112 million.
- EBITDA increased by 20.6% compared to H1 FY24.
- On track to deliver FY25 guidance with gross profit expected to be between $218 million and $226 million.
- Improved operating efficiency with operating expenses being managed effectively.
- Tyro Health is expected to contribute significantly to gross profit from FY26.
- Positive trends in Tyro's banking proposition demonstrate value to merchants.
- Tyro is investing in technology to enhance customer experience and payment solutions.
- The firm reported a significant increase in active merchant accounts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| National Storage REIT (NSR) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$3,270 |
NSR Half Year Results Presentation
|
26 Feb 2025 8:11AM |
$2.250 |
$2.350 |
risen by
4.44%
|
|
| Tyro Payments Limited (TYR) ORDINARY FULLY PAID |
Financials |
$486 |
Tyro Payments FY25 Interim Report
|
26 Feb 2025 8:11AM |
$0.895 |
$0.920 |
risen by
2.79%
|
|
TYR - Price-sensitive ASX Announcement
Full Release
Key Points
- Gross profit increased by 6.5% to $112.0 million.
- EBITDA rose by 20.6% to $33.0 million.
- Statutory profit before tax increased by 99.6% to $10.3 million.
- Active Tyro Bank Account users grew by 34% compared to the previous year.
- The company aims to provide integrated payments and banking solutions for SMEs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| National Storage REIT (NSR) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$3,270 |
NSR Half Year Results Announcement
|
26 Feb 2025 8:11AM |
$2.250 |
$2.350 |
risen by
4.44%
|
|
| ImpediMed Limited (IPD) ORDINARY FULLY PAID |
Health Care |
$67 |
Appendix 4D and Interim Financial Report
|
26 Feb 2025 8:11AM |
$0.045 |
$0.033 |
fallen by
26.67%
|
|
IPD - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue for half-year ended 31 December 2024 was $6.0 million.
- Revenue increased by $1.2 million or 26% compared to the prior period.
- Net loss for the period was $11.1 million, up from $9.7 million year-over-year.
- Operating expenses totaled $17.3 million, compared to $17.1 million in the prior corresponding period.
- ImpediMed focuses on bioimpedance spectroscopy technology for medical applications.
- A new growth capital facility of $15 million was secured for ongoing operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vitura Health Limited (VIT) ORDINARY FULLY PAID |
Health Care |
$48 |
H1 FY2025 financial results
|
26 Feb 2025 8:11AM |
$0.099 |
$0.072 |
fallen by
27.27%
|
|
VIT - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue of $62.7 million, up 4.5% from the previous year.
- Normalized EBITDA of $4.6 million, reflecting acquisition costs and legal dispute resolutions.
- Normalized profit after income tax down 42% to $2.2 million.
- New CEO Geoff Cockerill appointed and a strategy reset being implemented.
- Acquisition of Releaf Group assets providing access to 30,000 additional patients.
- Doctors on Demand telehealth business grew significantly with a 230% increase in revenue.
- Successful settlement of legacy legal disputes reducing operational risks.
- Acquisition of Candor Medical completed, adding 15,000 active patients.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Thorney Opportunities Ltd (TOP) ORDINARY FULLY PAID |
Financials |
$114 |
Update - Notification of buy-back - TOP
|
26 Feb 2025 8:10AM |
$0.630 |
$0.640 |
risen by
1.59%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
